HCPCS G2089: Most Recent Hemoglobin A1c 7.0–9.0%

HCPCS Level II code G2089 designates a most recent hemoglobin A1c (HbA1c) result in the 7.0%–9.0% range. Nationally, standardized reporting of HbA1c strata supports quality measurement, risk adjustment, and program eligibility decisions tied to diabetes management. Clear use of this code allows payers and providers to communicate glycemic control status without transmitting raw laboratory values.

Key payers included in this overview are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the code's clinical meaning and service contexts, followed by coverage and billing considerations used by major payers. The publication outlines how G2089 is applied for diabetes monitoring, typical sites of service where it appears, and the role such codes play in quality measurement and reporting.

What readers will learn: the clinical context for using G2089, which payers commonly recognize the code, where it is typically reported (outpatient/ambulatory settings and labs), and where to find additional billing guidance. Data not included in the input—such as associated taxonomies, specific ICD-10 pairings, and payer-specific reimbursement details—is noted as unavailable.

Billing Code Overview

HCPCS Level II code G2089 describes the most recent hemoglobin A1c (HbA1c) level of 7.0% to 9.0%. This code is used to report a current laboratory control measure for glycemic status in patients with diabetes.

Service Type: Laboratory result / Diabetes monitoring

Typical Site of Service: Outpatient clinic, physician office, laboratory, or other ambulatory settings where HbA1c testing and diabetes management occur

Data not available in the input.

Clinical Context

A 58-year-old patient with established type 2 diabetes mellitus presents to a primary care clinic for routine chronic disease management. The clinician orders a point-of-care or laboratory hemoglobin A1c test; the resulting value is 7.8%, which falls in the range described by billing code G2089 (most recent HbA1c level 7.0 to 9.0%). The clinical workflow includes: patient check-in and vitals, review of current medications and adherence, performance of the HbA1c assay (either in-office point-of-care device or venous sample sent to the lab), documentation of the most recent HbA1c value in the medical record, and a focused visit note addressing glucose control and any adjustments to therapy. Typical sites of service include outpatient primary care clinics, endocrinology offices, community health centers, and ambulatory laboratory facilities. Common encounter scenarios include routine diabetes follow-up visits, medication titration visits, and chronic care management encounters where the most recent HbA1c result informs clinical decision-making.

Coding Specifications

Modifier	Description	When to Use
`22`	Increased procedural services	Use when work required to report the HbA1c result is substantially greater than usual (e.g., extensive documentation or counseling beyond typical).

Taxonomy Code	Specialty	Notes
`207Q00000X`	Family Medicine	Primary care providers commonly order and document HbA1c testing.
`207R00000X`	Internal Medicine	Internists manage chronic diabetes care and interpret HbA1c results.
`207L00000X`	Endocrinology	Specialists evaluate complex diabetes cases and adjust advanced therapies based on HbA1c.
`363L00000X`	Clinical Laboratory	Laboratory professionals perform and report HbA1c assays.
`208D00000X`	Nurse Practitioner	Advanced practice clinicians frequently order and manage diabetes testing and follow-up.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`E11.9`	Type 2 diabetes mellitus without complications	Common primary diagnosis for patients monitored with HbA1c; `G2089` indicates most recent A1c within 7.0–9.0%.
`E11.65`	Type 2 diabetes mellitus with hyperglycemia	Relevant when the A1c in the `G2089` range reflects suboptimal control and hyperglycemia management is considered.
`E10.9`	Type 1 diabetes mellitus without complications	Type 1 diabetic patients also have HbA1c monitored; result range in `G2089` may apply to some adults with type 1 diabetes.
`R73.9`	Hyperglycemia, unspecified	Used when abnormal glucose control is identified and HbA1c testing is part of the diagnostic or monitoring process.
`Z13.1`	Encounter for screening for diabetes mellitus	HbA1c testing can be performed as part of screening or risk assessment in outpatient settings.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`83036`	Hemoglobin A1c; electromechanical assay	Common laboratory method for measuring HbA1c values; often the CPT counterpart for billing lab processing of the specimen that yields the `G2089` clinical result.
`83037`	Hemoglobin A1c; by high-performance liquid chromatography (HPLC)	Alternative laboratory method for HbA1c measurement; used when HPLC technique is employed for definitive quantification.
`36415`	Collection of venous blood by venipuncture	Performed when a venous sample is required for laboratory HbA1c testing.
`99000`	Handling and/or conveyance of specimen for transfer from physician office to another facility	Used when specimens are shipped to an external laboratory for HbA1c testing.
`99490`	Chronic care management services, at least 20 minutes of clinical staff time directed by a physician or other qualified health care professional, per calendar month	May be billed in longitudinal care for patients with diabetes when HbA1c results drive ongoing management and care coordination.

OpenPayer

Summary & Overview